Cited by 113DNA Repair MechanismsChromosomal and Genetic VariationsGenomic variations and chromosomal abnormalities

BRCA1 and S phase DNA repair pathways restrict LINE-1 retrotransposition in human cells

Open access
Mita, Paolo, Sun, Xiaoji, Fenyö, David, Kahler, David J., Li, Donghui, Agmon, Neta, Wudzinska, Aleksandra, Keegan, Sarah +3 more·2020·Nature Structural & Molecular Biology

Published version of a preprint

Abstract

Long interspersed element-1 (LINE-1, or L1) is the only autonomous retrotransposon that is active in human cells. Different host factors have been shown to influence L1 mobility; however, systematic analyses of these factors are limited. Here, we developed a high-throughput microscopy-based retrotransposition assay that identified the double-stranded break (DSB) repair and Fanconi anemia (FA) factors active in the S/G2 phase as potent inhibitors and regulators of L1 activity. In particular, BRCA1, an E3 ubiquitin ligase with a key role in several DNA repair pathways, directly affects L1 retrotransposition frequency and structure and plays a distinct role in controlling L1 ORF2 protein translation through L1 mRNA binding. These results suggest the existence of a 'battleground' at the DNA replication fork between homologous recombination (HR) factors and L1 retrotransposons and reveal a potential role for L1 in the genotypic evolution of tumors characterized by BRCA1 and HR repair deficiencies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41594-020-0374-z

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DNA lesions, in particular dsDNA breaks, can arise as collateral damage associated with retrotransposition.

    “DNA lesions, in particular dsDNA breaks (DSB), can arise as ‘collateral damage’ associated with retrotransposition19, 20, 102.”

    From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [20]

    The Results section on target-site deletions reports DNA nicking and deletions during LINE-1 retrotransposition, supporting the broader point that it can produce DNA lesions. The Discussion section on replication forks also says LINE-1 may create stalled forks through endonuclease-mediated nicking. Our copy does not itself establish that the collateral lesions are specifically double-strand breaks; that point appears in the title of a work listed in the References. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 95 · Cited by 113

Authors
Mita, P., Sun, X., Fenyö, D., Kahler, D. J., Li, D., Agmon, N., Wudzinska, A., Keegan, S., Bader, J. S., Yun, C., & Boeke, J. D.
Affiliations
  • NYU Langone Health (US)
  • Johns Hopkins University (US)
Corresponding author
  • Mita, Paolo
  • Boeke, Jef D.
Venue
Nature Structural & Molecular Biology
Published
2020-02
Volume
27
Issue
2
Pages
179-191
ISSN
  • 1545-9985 (ISSN-L)
  • 1545-9993
OpenAlex
W3005417928
Cited by
113
References
95
Citations by year
2026: 13 · 2025: 21 · 2024: 16 · 2023: 19 · 2022: 17 · 2021: 16 · 2020: 11
FWCI
5.11
Type
journal article
Language
en
Open access
Locations
  • Nature Structural & Molecular Biology (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • New York State Stem Cell Science (Contract C026719, C026719)
  • National Institutes of Health (P30CA16087)
  • National Institute on Aging (P01AG051449)
  • National Cancer Institute (NIH/NCI P30CA16087, P30CA 16087)
  • National Institute of General Medical Sciences (P50GM107632)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Chromosomal and Genetic Variations
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
LINE-1 retrotransposition, BRCA1, Fanconi anemia pathway, homologous recombination, replication fork, DNA double-strand break repair, siRNA screen
MeSH terms
Cell Line, DNA Repair, Fanconi Anemia, HeLa Cells, Humans, Microscopy, S Phase, Gene Deletion, BRCA1 Protein, Long Interspersed Nucleotide Elements, DNA Breaks, Double-Stranded, HEK293 Cells, Homologous Recombination, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review